arrow-down arrow-left arrow-right check clock edit filter phone question-mark search submit-arrow

 

 

"At myTomorrows, we believe that everyone should have access to all suitable treatment options, whenever available, wherever they exist. ”

"At myTomorrows, we believe that everyone should have access to all suitable treatment options, whenever available, wherever they exist. ”

 

Ronald Brus MD,  Founder  & CEO of myTomorrows

 

 

How myTomorrows works

 

Schedule a consult using our online calendar

Speak with a myTomorrows medical expert

We provide information about possible treatment options

 

Review these options with your doctor

Your doctor can proceed to request the treatment, if applicable

 

 

 

Who can we help?

 

Patients...

  • • with a life threatening or debilitating disease
  • • with no remaining viable treatment options with registered medicines
  • • who cannot enter an available Clinical Trial with the medicine accessible through the Early Access Program
  • • with a doctor willing to investigate possible treatment options

 

How can we help?

 

myTomorrows wants to help patients who run out of viable treatment options and their doctors. There might be a possibility to get a treatment with a medicine in development.

 

Medicines in development are not yet approved for a specific condition and/or in your country, but they have shown hopeful results during testing and could potentially benefit patients in need.

 

Treatment with this type of unlicensed medicines may be possible by participating in a Clinical Trial or an Early Access Program.

 

However, the process of accessing medicines in development is often complex, lengthy and burdensome. Even for a doctor. 

 

That’s why we support patients who run out of treatment options, and their doctors, getting access to medicines in development.

 

 

What does it cost?

 

Our service is free. Reimbursement of the medicine differs per country.

 

We don't charge patients or doctors for our services.

 

At myTomorrows we believe that everyone should have access to all suitable treatment options.